Search results for "ddc:61"

showing 10 items of 588 documents

Interleukin 10 restores lipopolysaccharide-induced alterations in synaptic plasticity probed by repetitive magnetic stimulation

2020

Systemic inflammation is associated with alterations in complex brain functions such as learning and memory. However, diagnostic approaches to functionally assess and quantify inflammation-associated alterations in synaptic plasticity are not well-established. In previous work, we demonstrated that bacterial lipopolysaccharide (LPS)-induced systemic inflammation alters the ability of hippocampal neurons to express synaptic plasticity, i.e., the long-term potentiation (LTP) of excitatory neurotransmission. Here, we tested whether synaptic plasticity induced by repetitive magnetic stimulation (rMS), a non-invasive brain stimulation technique used in clinical practice, is affected by LPS-induc…

lcsh:Immunologic diseases. AllergyLipopolysaccharides0301 basic medicinenon-invasive brain stimulationInterleukin-1betaImmunologyTNFα-reporter mouseMice TransgenicStimulationNeurotransmissionHippocampusSynaptic TransmissionneuroinflammationInterferon-gammaMice03 medical and health sciences0302 clinical medicineGenes Reportertranscranial magnetic stimulationAnimalsImmunology and Allergyddc:610NeuroinflammationOriginal ResearchInflammationNeuronsNeuronal Plasticitysynaptic plasticityInterleukin-6Tumor Necrosis Factor-alphaChemistryLong-term potentiationInterleukin-10Mice Inbred C57BLOrganoids030104 developmental biologyBrain stimulationSynaptic plasticityExcitatory postsynaptic potentialTumor necrosis factor alphaMicrogliainterleukin 10lcsh:RC581-607Neuroscience030217 neurology & neurosurgery
researchProduct

Control of Murine Cytomegalovirus Infection by γδ T Cells

2015

Infections with cytomegalovirus (CMV) can cause severe disease in immunosuppressed patients and infected newborns. Innate as well as cellular and humoral adaptive immune effector functions contribute to the control of CMV in immunocompetent individuals. None of the innate or adaptive immune functions are essential for virus control, however. Expansion of γδ T cells has been observed during human CMV (HCMV) infection in the fetus and in transplant patients with HCMV reactivation but the protective function of γδ T cells under these conditions remains unclear. Here we show for murine CMV (MCMV) infections that mice that lack CD8 and CD4 αβ-T cells as well as B lymphocytes can control a MCMV i…

lcsh:Immunologic diseases. AllergyMuromegalovirusAdoptive cell transferCD3 ComplexT cellImmunologyPopulation-MicrobiologyMiceImmune systemT-Lymphocyte SubsetsMedizinische FakultätVirologyGeneticsmedicineAnimalsCytotoxic T cellddc:610educationlcsh:QH301-705.5Molecular BiologyMice Knockouteducation.field_of_studybiologyvirus diseasesHerpesviridae InfectionsFlow CytometryAdoptive TransferVirologyHigh-Throughput Screening AssaysMice Inbred C57BLmedicine.anatomical_structurelcsh:Biology (General)Immunologybiology.proteinParasitologyAntibodyStem celllcsh:RC581-607CD8Research ArticlePLOS Pathogens
researchProduct

IL-2 Expression in Activated Human Memory FOXP3(+) Cells Critically Depends on the Cellular Levels of FOXP3 as Well as of Four Transcription Factors …

2012

The human CD4(+)FOXP3(+) T cell population is heterogeneous and consists of various subpopulations which remain poorly defined. Anergy and suppression are two main functional characteristics of FOXP3(+)Treg cells. We used the anergic behavior of FOXP3(+)Treg cells for a better discrimination and characterization of such subpopulations. We compared IL-2-expressing with IL-2-non-expressing cells within the memory FOXP3(+) T cell population. In contrast to IL-2-non-expressing FOXP3(+) cells, IL-2-expressing FOXP3(+) cells exhibit intermediate characteristics of Treg and Th cells concerning the Treg cell markers CD25, GITR, and Helios. Besides lower levels of FOXP3, they also have higher levels…

lcsh:Immunologic diseases. AllergyT cellLymphocytePopulationImmunologychemical and pharmacologic phenomenaBiologylymphocyteFlow cytometrytranscription factorsmedicineImmunology and Allergycytokine expressionIL-2 receptorddc:610educationTranscription factorOriginal Researcheducation.field_of_studyIL-2 expressionmedicine.diagnostic_testT cell activationflow cytometryhuman Treg cellsFOXP3T cellhemic and immune systemsmemory Th cellsPhenotypeCell biologymedicine.anatomical_structureImmunologylcsh:RC581-607610 Medizin und GesundheitFrontiers in immunology
researchProduct

The NG2 Proteoglycan Protects Oligodendrocyte Precursor Cells against Oxidative Stress via Interaction with OMI/HtrA2.

2015

The NG2 proteoglycan is characteristically expressed by oligodendrocyte progenitor cells (OPC) and also by aggressive brain tumours highly resistant to chemo- and radiation therapy. Oligodendrocyte-lineage cells are particularly sensitive to stress resulting in cell death in white matter after hypoxic or ischemic insults of premature infants and destruction of OPC in some types of Multiple Sclerosis lesions. Here we show that the NG2 proteoglycan binds OMI/HtrA2, a mitochondrial serine protease which is released from damaged mitochondria into the cytosol in response to stress. In the cytosol, OMI/HtrA2 initiates apoptosis by proteolytic degradation of anti-apoptotic factors. OPC in which NG…

lcsh:MedicineApoptosisdrug effects [Cytosol]HTRA2 protein humangenetics [RNA Small Interfering]genetics [Serine Endopeptidases]genetics [Glioblastoma]570 Life sciencespathology [Glioblastoma]MiceCytosolCerebellumpathology [Cerebellum]RNA Small Interferinglcsh:Sciencemetabolism [Antigens]Mice Knockoutchondroitin sulfate proteoglycan 4metabolism [Proteoglycans]Brain NeoplasmsSerine Endopeptidasesdrug effects [Mitochondria]metabolism [Cerebellum]High-Temperature Requirement A Serine Peptidase 2Mitochondriametabolism [Brain Neoplasms]Gene Expression Regulation Neoplasticpharmacology [Antibodies Neutralizing]genetics [Mitochondrial Proteins]Proteoglycans570 BiowissenschaftenResearch ArticleProtein BindingSignal Transductionpathology [Brain Neoplasms]Primary Cell Culturedrug effects [Cerebellum]drug effects [Apoptosis]metabolism [Mitochondrial Proteins]Mitochondrial Proteinsantagonists & inhibitors [Proteoglycans]pharmacology [Hydrogen Peroxide]genetics [Antigens]Cell Line Tumormetabolism [Serine Endopeptidases]AnimalsHumansddc:610metabolism [RNA Small Interfering]Antigenslcsh:RHtra2 protein mouseHydrogen Peroxidemetabolism [Mitochondria]Antibodies Neutralizinggenetics [Proteoglycans]genetics [Brain Neoplasms]Mice Inbred C57BLOxidative Stressnervous systemlcsh:Qmetabolism [Cytosol]Glioblastomametabolism [Glioblastoma]
researchProduct

Loss Aversion and Risk Aversion in Non-Clinical Negative Symptoms and Hypomania

2020

In the field of behavioral decision-making, “loss aversion” is a behavioral phenomenon in which individuals show a higher sensitivity to potential losses than to gains. Conversely, “risk averse” individuals have an enhanced sensitivity/aversion to options with uncertain consequences. Here we examine whether hypomania or negative symptoms predict the degree of these choice biases. We chose to study these two symptom dimensions because they present a common theme across many syndromes with compromised decision-making. In our exploratory study, we employed a non-clinical sample to dissociate the hypomanic from negative symptom dimension regarding choice behavior. We randomly selected a sample …

lcsh:RC435-571610 Medicine & healthLoss-aversionAffect (psychology)loss-aversion170 Ethics2738 Psychiatry and Mental Health03 medical and health sciencesddc:616.890302 clinical medicineLoss aversionlcsh:PsychiatrymedicineEnhanced sensitivity10237 Institute of Biomedical EngineeringRisk-aversionrisk-aversionnegative symptomsPsychiatryNegative symptomStudent populationRisk aversiondecision-makingBrief Research ReportHypomania030227 psychiatryPsychiatry and Mental healthHypomaniaNon clinical10054 Clinic for Psychiatry Psychotherapy and Psychosomaticsloss-aversion; risk-aversion; decision-making; negative symptoms; hypomaniahypomaniaNegative symptomsmedicine.symptomPsychology030217 neurology & neurosurgeryClinical psychologyDecision-makingFrontiers in Psychiatry
researchProduct

Temperature effects explain continental scale distribution of cyanobacterial toxins

2018

Insight into how environmental change determines the production and distribution of cyanobacterial toxins is necessary for risk assessment. Management guidelines currently focus on hepatotoxins (microcystins). Increasing attention is given to other classes, such as neurotoxins (e.g., anatoxin-a) and cytotoxins (e.g., cylindrospermopsin) due to their potency. Most studies examine the relationship between individual toxin variants and environmental factors, such as nutrients, temperature and light. In summer 2015, we collected samples across Europe to investigate the effect of nutrient and temperature gradients on the variability of toxin production at a continental scale. Direct and indirect…

light climate0106 biological sciencesthermoclineBacterial toxinstoksiinitlimit of quantitationToxines bacterianesMicrocystin-LRToxicology01 natural sciencesAnatoxin-aanalogs and derivativesBLOOMSDirect EffectsuracilWater Pollutantschemistry.chemical_classificationTemperaturesFRESH-WATERlatitudemaximum buoyancy frequency6. Clean waterclimate changeIndirect effectsEUTROPHICATIONmicrocystin RRarticlesGROWTHlämpötilaLAKESmicrocystin; anatoxin; cylindrospermopsin; temperature; direct effects; indirect effects; spatial distribution; European Multi Lake Surveyepilimnetic temperatureta1172cyanobacteria lakes climate warming microcystin; anatoxin; cylindrospermopsin; temperature; direct effects; indirect effects; spatial distribution; European Multi Lake SurveyZoologyArticlewater pollutantMICROCYSTIS-AERUGINOSAAlkaloidsSettore BIO/07 - ECOLOGIANATURAL SCIENCES. Biology.Spatial distributionMicrocystis aeruginosaUracillakesyanobakteeritIndirect Effectsliquid chromatography-mass spectrometry1172 Environmental sciencesEkologinutrient010604 marine biology & hydrobiologylcsh:RmicrobiologyClimatic changesmicrocystin LRAnatoxinLakesSpatial Distributionchemistrynodularinmicrobial diversityphytoplanktonta1181CylindrospermopsinTropanesCyanobacteriaAquatic Ecology and Water Quality ManagementanalysisHealth Toxicology and Mutagenesislcsh:Medicineenvironmental parameters010501 environmental sciencesmedicine.disease_causenitrogenchemistry.chemical_compoundsea surface temperatureenvironmental factorddc:550Canvi climàticphosphorusPRIRODNE ZNANOSTI. Biologija.limit of detectionEcologyCyanobacteria ToxinsbiologyTemperaturelevinneisyysmicrocystin ; anatoxin ; cylindrospermopsin ; temperature ; direct effects ; indirect effects ; spatial distribution ; European Multi Lake SurveyNodularintropane derivativeEuropeDAPHNIA-MAGNAİndirect EffectsCylindrospermopsinDirect effectsmicrobial communityEnvironmental Monitoringhigh performance liquid chromatographyMicrocystinsClimate ChangeBacterial ToxinsMicrocystinMicrocystinCyanobacteriavälittömät oikeusvaikutuksetcyanobacteriumddc:570geographic distributionmedicinebacterial toxincontrolled studyddc:610Institut für Biochemie und Biologie0105 earth and related environmental sciencesnonhumanWIMEKToxinlongitudePHYTOPLANKTON ASSEMBLAGESEuropean Multi Lake SurveyAquatic EcologyNITROGEN AVAILABILITYanatoxin aAquatische Ecologie en Waterkwaliteitsbeheerbiology.organism_classificationClimatic changeCLIMATE13. Climate actionresponse variableCanvis climàtics
researchProduct

SETAC GLB and SETAC Europe SAC: a liaison promoting the next generation of ecotoxicologists and environmental chemists

2018

Environmental sciences Europe 30(1), 41s12302-018-0171-z (2018). doi:10.1186/s12302-018-0171-z

media_common.quotation_subject0208 environmental biotechnologyenvironmental chemistsFace (sociological concept)61002 engineering and technology010501 environmental sciencesecotoxicologists01 natural sciencesGermanddc:570Gratitudeddc:610lcsh:Environmental sciences0105 earth and related environmental sciencesmedia_commonlcsh:GE1-350lcsh:Environmental lawympäristökemiaPollutionlanguage.human_language020801 environmental engineeringekotoksikologialcsh:K3581-3598EditoriallanguageEngineering ethics
researchProduct

Repurposing of the ALK inhibitor crizotinib for acute leukemia and multiple myeloma cells

2021

Crizotinib was a first generation of ALK tyrosine kinase inhibitor approved for the treatment of ALK-positive non-small-cell lung carcinoma (NSCLC) patients. COMPARE and cluster analyses of transcriptomic data of the NCI cell line panel indicated that genes with different cellular functions regulated the sensitivity or resistance of cancer cells to crizotinib. Transcription factor binding motif analyses in gene promoters divulged two transcription factors possibly regulating the expression of these genes, i.e., RXRA and GATA1, which are important for leukemia and erythroid development, respectively. COMPARE analyses also implied that cell lines of various cancer types displayed varying degr…

medicine.drug_classPharmaceutical Scienceacute myeloid leukemiaArticletranscriptomicsPharmacy and materia medicaDrug Discoverytyrosine kinase inhibitorsmedicineCytotoxic T cellnetwork pharmacologyddc:610biologyCrizotinibdrug repurposingChemistryTopoisomeraseRMyeloid leukemiaCell cyclemedicine.diseaseALK inhibitorRS1-441multiple myelomaLeukemiaCancer cellbiology.proteinCancer researchMolecular MedicineMedicinemedicine.drug
researchProduct

Treatment choices and neuropsychological symptoms of a large cohort of early MS

2018

ObjectiveTo assess clinical characteristics, distribution of disease-modifying treatments (DMTs), and neuropsychological symptoms in a large cohort of patients with early-stage MS.MethodsThe German National MS Cohort is a multicenter prospective longitudinal cohort study that has recruited DMT-naive patients with clinically isolated syndrome (CIS) and relapsing-remitting MS (RRMS) since 2010. We evaluated their baseline characteristics and the prevalence of neuropsychological symptoms.ResultsOf 1,124 patients, with a 2.2:1 female-to-male ratio and median age at onset of 31.71 years (interquartile range [IQR]: 26.06–40.33), 44.6% and 55.3% had CIS and RRMS, respectively. The median Expanded …

medicine.medical_specialty41610 Medicine & healthArticle03 medical and health sciences0302 clinical medicineQuality of lifeInterquartile rangeInternal medicinemedicineddc:610030212 general & internal medicine10. No inequalityDepression (differential diagnoses)Expanded Disability Status ScaleClinically isolated syndromebusiness.industryMultiple sclerosisNeuropsychologymedicine.disease3. Good healthNeurologyCohortNeurology (clinical)businessFunction and Dysfunction of the Nervous System030217 neurology & neurosurgery
researchProduct

Sunlight exposure exerts immunomodulatory effects to reduce multiple sclerosis severity

2021

AbstractBackgroundMultiple sclerosis (MS) disease risk is associated with reduced sun exposure. This study assessed the relationship between measures of sun-exposure (vitamin D (vitD), latitude) and MS disease severity, the mechanisms of action, and effect-modification by medication and sun-sensitivity associated MC1R variants.MethodsTwo multi-center cohort studies (nNationMS=946, nBIONAT=991). Outcomes were the multiple sclerosis severity score (MSSS) and the number of Gd-enhancing lesion (GELs). RNAseq of four immune cell populations before and after UV-phototherapy of five MS patients.ResultsHigh serum vitD was associated with reduced MSSS (PNationMS=0.021; PBIONAT=0.007) and reduced ris…

medicine.medical_specialty610 Medicine & healthDiseaseGastroenterologyLesionImmune systemInterferonInternal medicineVitamin D and neurologyMedicineddc:610610 Medicine & healthBeneficial effectsSunlightSystemic lupus erythematosusMultidisciplinaryLow latitudebusiness.industryMultiple sclerosismedicine.diseaseddc:Cardiovascular and Metabolic DiseasesDisease riskmedicine.symptombusinessmedicine.drugCohort study
researchProduct